Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Schwetz Is Acting Commissioner: Is RU-486 New Touchstone?

This article was originally published in The Gray Sheet

Executive Summary

Acting Deputy Commissioner Bernard Schwetz, PhD, will oversee the agency following the resignation of FDA Commissioner Jane Henney, MD.

You may also be interested in...



FDA Commissioner Von Eschenbach Makes Resignation Plans Official

FDA Commissioner Andrew von Eschenbach will resign from the agency Jan. 20, which means the Obama administration needs to have an interim replacement ready to go on Inauguration Day

FDA Commissioner Von Eschenbach Makes Resignation Plans Official

FDA Commissioner Andrew von Eschenbach will resign from the agency Jan. 20, which means the Obama administration needs to have an interim replacement ready to go on Inauguration Day

Former FDA Commissioner Henney

Pharmaceutical distributor AmerisourceBergen Corp. elects Jane Henney, MD, to its nine-member board of directors. Henney currently is the senior scholar in residence at the Association of Academic Health Centers in Washington, D.C. She resigned her FDA post in January 2001 (1"The Gray Sheet" Jan. 22, 2001, p. 7)...

UsernamePublicRestriction

Register

OM006145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel